Andrew G Sikora

7PUBLICATIONS
107CO-AUTHORS
Cancer diagnosisSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 14, 2026
IL-1α Expands SLC2A1highSPP1highIFNlow Myeloid Cells to Drive Immune Escape and Malignant Transformation of Pre-cancers.

|May 27, 2026
Tumor Implantation Site of Syngeneic Oral Cancer Models Differentially Induces Site-Dependent Local and Systemic Immunosuppression.

|Mar 17, 2026
Neoadjuvant chemoimmunotherapy improves response rates in head and neck cancer.

Jennifer L Anderson, Andrew G Sikora

|Dec 28, 2025
BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity.

Wang Gong, Hülya F Taner, Yuesong Wu

|Sep 03, 2024
Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors.

Allison J Nipper, Emilie A K Warren, Kershena S Liao

|Mar 03, 2023
International Multi-Specialty Expert Physician Preoperative Identification of Extranodal Extension n Oropharyngeal Cancer Patients using Computed Tomography: Prospective Blinded Human Inter-Observer Performance Evaluation.

Onur Sahin, Serageldin Kamel, Kareem A Wahid

Pageof 2

Frequent Collaborators

2 joint publications

Zackary R Fitzsimonds

2 joint publications

Jeffrey N Myers

2 joint publications

Vlad C Sandulache

2 joint publications

Shadmehr Demehri